Category: HypertensionSyndicate content

Ablative Solutions tests infusion ablation catheter as hypertension treatment

October 20, 2014 by Alexander Soule

Ablative Solutions begins testing its infusion ablation catheter as a potential treatment for hypertension.

Ablative Solutions tests infusion ablation catheter as hypertension treatment

TCT 2014: Another trial shows no benefit for renal denervation in hypertension

September 17, 2014 by Brad Perriello

Another trial of Medtronic's Symplicity renal denervation device in treating hypertension shows no benefit compared with a sham procedure.

TCT 2014: Another Medtronic trial shows no benefit for renal denervation in hypertension

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

TCT 2014 Roundup

September 15, 2014 by Brad Perriello

A roundup of studies released at the annual Transcatheter Cardiovascular Therapies conference in Washington this week.

TCT 2014 Roundup

Here's a look at some of the news coming out of Washington at the 26th annual Transcatheter Cardiovascular Therapies conference this week:

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic's renal denervation no better at 1 year, researchers say

September 5, 2014 by Arezu Sarvestani

Medtronic's failed Symplicity HTN-3 renal denervation study doesn't look any better with 12 months of follow-up, according to new results presented at this year's European Society of Cardiology Congress.

Medtronic's renal denervation no better at 1 year, study finds

Renal denervation technologies took another blow this week as 1-year results from Medtronic's (NYSE:MDT) much-lamented Symplicity HTN-3 trial still turned out no signs that the treatment is effective against hypertension.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Renal denervation isn't dead, despite Medtronic trial's failure

September 2, 2014 by Brad Perriello

The failure of Medtronic's Symplicity 3 trial doesn't mean the end of renal denervation in treated resistant hypertension, especially in Europe, but future studies face a high bar set by the Medtronic trial's sham control arm.

Renal denervation isn't dead, despite Medtronic trial's failure

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Kona Medical launches hypertension trial for non-invasive RDN device

August 29, 2014 by Brad Perriello

Kona Medical announces the launch of a clinical trial for its non-invasive Surround Sound renal denervation device for treating hypertension.

Kona Medical launches hypertension trial for non-invasive RDN device

Kona Medical said this week that it's launched a clinical trial of the non-invasive renal denervation device for treating hypertension it calls Surround Sound.

Can Big Data help detect silent hypertension? | MassDevice.com On Call

July 17, 2014 by Arezu Sarvestani

Researchers develop a "surveillance system" to monitor patients' electronic health records for signs of undiagnosed hypertension.

MassDevice.com On Call

MASSDEVICE ON CALL — A computer algorithm may be able to help physicians monitor patients for signs of hypertension, a disease known as "the silent killer."

Researchers at Northwestern Medicine developed a trio of algorithms to review patients' electronic health records and alert healthcare providers that a patient may have or may be developing hypertension.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp